LifeMD (NASDAQ:LFMD) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.05) by 120 percent. This is unchanged from the same period last year. The company reported quarterly sales of $65.70 million which beat the analyst consensus estimate of $62.55 million by 5.03 percent. This is a 48.83 percent increase over sales of $44.14 million the same period last year.